Loading stock data…
Loading stock data…
US$13.04
Get one email when EYPT crosses your level. Checked every 15 minutes during market hours.
▼ -0.81 (-5.85%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
44.3
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.18
Bearish momentumMACD below its signal line (0.28).
50-day average
13.27
Price belowShort-term trend reference.
200-day average
14.16
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
EyePoint Pharmaceuticals Inc. is a specialty biopharmaceutical company focused on developing and commercializing innovative ophthalmic products. Its primary purpose is to treat serious eye disorders, particularly targeting diseases like wet age-related macular degeneration (AMD), diabetic macular edema, and retinal vein occlusion. EyePoint's unique approach leverages drug delivery technologies which offer sustained-release treatments, enhancing patient outcomes by providing consistent therapeuti…
eyepointpharma.com6 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (18 analysts, 2026-07-01)
6 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (18 analysts, 2026-06-01)
6 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (18 analysts, 2026-05-01)
6 strong buy · 11 buy · 1 hold · 0 sell · 0 strong sell (18 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-06 | -0.81 | -0.99 | ✗ Miss |
| 2026-04-15 | 0.5 | 0.53 | ✓ Beat |
| 2026-02-16 | -10.85 | -0.59 | ✓ Beat |
| 2026-02-03 | 3.32 | 3.33 | ✓ Beat |
Companies in the same industry, via Finnhub